CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
406-420 of 1187
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
MinuteCE®Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Rethinking Schizophrenia Treatment Through Muscarinic Modulation
CME/CERethinking Schizophrenia Treatment Through Muscarinic Modulation
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®Spotlight on Asia-Pacific: Practice Beyond Borders
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
MinuteCE®Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
- advertisement
RSV in Infants and Young Children: Are You Taking It Seriously Enough?
CME/CERSV in Infants and Young Children: Are You Taking It Seriously Enough?
Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
CME/CEMuscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
A Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
CME/CEA Clear Horizon in Plaque Psoriasis: An Update on Investigational Oral Therapies
IgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
CME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME/CEEngaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Navigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
CME/CENavigating CMV Post-Transplant: Perspectives on Complex Cases: A Clinical Forum®
- advertisement
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
MinuteCE®Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies





























































